Can a chaotic FDA still deliver on faster drug development? Summary: Despite leadership turnover and organizational instability at the FDA, regulators and industry remain committed to accelerating drug development, though experts caution that achieving faster clinical trials will require clear implementation strategies, sufficient staffing, and coordinated support across the broader U.S. healthcare ecosystem Click to […]